SCHEMBL8075296

SCHEMBL8075296

COc1cc2nc(N3CCC(Nc4nc(N)c(C(=O)O)nc4Cl)CC3)nc(N)c2cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 2/20 0.55
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HPGD P15428 4/20 0.54
GLA P06280 3/20 0.54
HSD17B10 Q99714 3/20 0.54
ADRA1A P35348 2/20 0.54
ADRA1B P35368 2/20 0.54
MAPK1 P28482 2/20 0.54
GAA P10253 2/20 0.54
TP53 P04637 1/20 0.54
TSHR P16473 1/20 0.54
SLC22A1 O15245 1/20 0.54
ABCC4 O15439 1/20 0.54
LMNA P02545 1/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
DRD1 P21728 1/20 0.54
ACHE P22303 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8077081 0.94 EHMT2 (0.56) EHMT2KDM4EALDH1A1HPGDGLA
SCHEMBL8071831 0.83 KDM4E (0.55) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL8071911 0.80 ADRA1A (0.62) ADRA1AADRA1B
SCHEMBL8071748 0.78 ADRA1A (0.60) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL8077031 0.78 KDM4E (0.55) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL11398578 0.76 KDM4E (0.65) KDM4EALDH1A1HPGD
SCHEMBL8077026 0.76 ADRA1A (0.60) ADRA1AADRA1BADRA2AADRA2BADRA2C
Water SCHEMBL11395027 0.75 KDM4E (0.63) KDM4EALDH1A1HPGD
SCHEMBL10838825 0.75 KDM4E (0.67) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL8071975 0.74 ADRA1A (0.56) ADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6156758-A Antibacterial quinazoline compounds ISIS PHARMACEUTICALS, INC. (US) 2000-12-05 US disclosed